GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (HKSE:02142) » Definitions » Gross Margin %

HBM Holdings (HKSE:02142) Gross Margin % : 77.07% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is HBM Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. HBM Holdings's Gross Profit for the six months ended in Dec. 2024 was HK$86.3 Mil. HBM Holdings's Revenue for the six months ended in Dec. 2024 was HK$111.9 Mil. Therefore, HBM Holdings's Gross Margin % for the quarter that ended in Dec. 2024 was 77.07%.


The historical rank and industry rank for HBM Holdings's Gross Margin % or its related term are showing as below:

HKSE:02142' s Gross Margin % Range Over the Past 10 Years
Min: 56.37   Med: 96.82   Max: 99.68
Current: 88.25


During the past 7 years, the highest Gross Margin % of HBM Holdings was 99.68%. The lowest was 56.37%. And the median was 96.82%.

HKSE:02142's Gross Margin % is ranked better than
84.35% of 741 companies
in the Biotechnology industry
Industry Median: 59.72 vs HKSE:02142: 88.25

HBM Holdings had a gross margin of 77.07% for the quarter that ended in Dec. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for HBM Holdings was 0.10% per year.


HBM Holdings Gross Margin % Historical Data

The historical data trend for HBM Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HBM Holdings Gross Margin % Chart

HBM Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Margin %
Get a 7-Day Free Trial 96.82 96.82 99.68 97.73 88.23

HBM Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.52 99.94 95.85 95.00 77.07

Competitive Comparison of HBM Holdings's Gross Margin %

For the Biotechnology subindustry, HBM Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HBM Holdings's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HBM Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where HBM Holdings's Gross Margin % falls into.


;
;

HBM Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

HBM Holdings's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=261.3 / 296.167
=(Revenue - Cost of Goods Sold) / Revenue
=(296.167 - 34.872) / 296.167
=88.23 %

HBM Holdings's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=86.3 / 111.929
=(Revenue - Cost of Goods Sold) / Revenue
=(111.929 - 25.66) / 111.929
=77.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


HBM Holdings  (HKSE:02142) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

HBM Holdings had a gross margin of 77.07% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


HBM Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of HBM Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


HBM Holdings Business Description

Traded in Other Exchanges
Address
218 Xinghu Street, Suite 202, Building A3, Suzhou Industrial Park, Suzhou, CHN, 215123
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Wang Jingsong 2101 Beneficial owner
Advantech Capital L.p.
Pang Kee Chan Hebert
Golden Link Investment Limited
Advantech Capital Partners Ltd.
Advantech Master Investment Limited
Astrazeneca Plc 2201 Interest of corporation controlled by you
Gic Private Limited 2102 Investment manager
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
Gic (ventures) Pte. Ltd. 2201 Interest of corporation controlled by you
Gic Special Investments Private Limited 2102 Investment manager
Owap Investment Pte Ltd 2101 Beneficial owner
Advantech Capital Holdings Ltd.
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

HBM Holdings Headlines

No Headlines